LADENBURG THALMANN FINANCIAL SERVICES INC. - ALDER BIOPHARMACEUTICALS INC ownership

ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 143 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 2.29 and the average weighting 0.5%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of ALDER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$54,000
+58.8%
2,866
-1.5%
0.00%
Q2 2019$34,000
-15.0%
2,911
-0.2%
0.00%
Q1 2019$40,000
+33.3%
2,9170.0%0.00%
Q4 2018$30,000
-40.0%
2,917
-3.4%
0.00%
Q3 2018$50,000
+13.6%
3,021
-11.9%
0.00%
Q2 2018$44,0000.0%3,4300.0%0.00%
Q1 2018$44,000
+7.3%
3,430
-5.7%
0.00%
Q4 2017$41,000
+24.2%
3,636
+30.9%
0.00%
Q3 2017$33,000
+50.0%
2,778
+44.5%
0.00%
Q2 2017$22,000
+450.0%
1,923
+762.3%
0.00%
Q1 2017$4,000
-42.9%
223
-40.2%
0.00%
Q4 2016$7,000
-41.7%
3730.0%0.00%
Q3 2016$12,000
+20.0%
3730.0%0.00%
Q2 2016$10,000
+66.7%
373
+67.3%
0.00%
Q1 2016$6,000
-33.3%
223
-10.4%
0.00%
Q4 2015$9,0000.0%2490.0%0.00%
Q3 2015$9,000
-83.9%
249
-76.3%
0.00%
-100.0%
Q2 2015$56,000
+93.1%
1,049
+4.9%
0.00%0.0%
Q1 2015$29,000
-87.1%
1,000
-87.1%
0.00%
-80.0%
Q4 2014$225,000
+1945.5%
7,750
+811.8%
0.01%
Q3 2014$11,000
-91.7%
850
-87.1%
0.00%
-100.0%
Q2 2014$132,0006,6000.00%
Other shareholders
ALDER BIOPHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Novo Holdings A/S 3,201,183$40,591,0003.96%
Cormorant Asset Management, LP 150,000$1,902,0000.39%
PFM Health Sciences, LP 1,034,030$13,112,0000.30%
Partner Investment Management, L.P. 23,660$300,0000.11%
PointState Capital LP 375,000$4,755,0000.09%
Spark Investment Management LLC 38,400$486,0000.07%
SECTORAL ASSET MANAGEMENT INC 89,300$1,132,0000.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 95,722$1,214,0000.05%
CADIAN CAPITAL MANAGEMENT, LP 120,000$1,522,0000.04%
Nicholas Investment Partners, LP 49,341$626,0000.04%
View complete list of ALDER BIOPHARMACEUTICALS INC shareholders